Identifying and establishing consensus on the most important safety features of GP computer systems: e-Delphi study.

Primary Care Information Services (PRIMIS), Division of Primary Care, University of Nottingham, The Medical School Queen's Medical Centre, Nottingham, UK.
Informatics in primary care 02/2005; 13(1):3-12.
Source: PubMed

ABSTRACT Our objective was to identify and establish consensus on the most important safety features of GP computer systems, with a particular emphasis on medicines management. We used a two-round electronic Delphi survey, completed by a 21-member multidisciplinary expert panel, all from the UK. The main outcome measure was percentage agreement of the panel members on the importance of the presence of a number of different safety features (presented as clinical statements) on GP computer systems. We found 90% or greater agreement on the importance of 32 (58%) statements. These statements, indicating issues considered to be of considerable importance (rated as important or very important), related to: computerised alerts; the need to avoid spurious alerts; making it difficult to override critical alerts; having audit trails of such overrides; support for safe repeat prescribing; effective computer-user interface; importance of call and recall management; and the need to be able to run safety reports. The high level of agreement among the expert panel members indicates clear themes and priorities that need to be addressed in any further improvement of safety features in primary care computing systems.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: First purified 11 years ago from clam ganglia, FMRFamide (Phe-Met-Arg-Phe-NH2) was quickly demonstrated to be cardioactive in several molluscan species. Subsequent discovery that FMRFamide, or FMRFamide-related peptides (FaRPs), were present in mammalian central nervous system and gastrointestinal tract prompted investigations into the effect of FMRFamide on mammals. FMRFamide has now been shown to be cardioexcitatory in mammals, to inhibit morphine-induced antinociception, and to block morphine-, defeat-, and deprivation-induced feeding. It also inhibits colonic propulsive motility, induces behavioral effects when administered intrathecally, and has been reported to have amnesic effects in rodents. A proposal has arisen that a FMRFamide-like substance is an endogenous opioid antagonist and has stimulated a search for such a substance. However, FMRFamide has only weak affinity for opioid receptors and not all the actions of FMRFamide appear to be explained by actions at opioid receptors. Alternative mechanisms have been proposed which suggest that FMRFamide acts as a neuromodulator.
    Peptides 01/1988; 9(4):915-22. · 2.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many drugs, when licensed, list a requirement for monitoring during treatment. Frequently, the information is vague and the adherence of the prescriber and patient to the monitoring regimen is variable and often poor. There is a need for rational monitoring schemes that clinicians can adhere to and that protect patients.
    Adverse Drug Reaction Bulletin 03/2010;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In 2001, the National Patient Safety Agency (NPSA) was created as part of a wider reform process to improve quality of care for patients in the National Health Services of England and Wales. The NPSA was charged with developing and implementing a national system for collecting and learning from reported patient safety incidents. Between 2003 and 2005, 303 447 incidents were reported from a wide range of health care settings. As a result, a range of interventions have been developed to improve safety. A number of lessons have been distilled from the experience of England and Wales, including that: clinical risk management system characteristics should be aligned with those of the national reporting system; and safety culture and information dissemination must be addressed at the same time as any new reporting system is implemented. These lessons should be of use to other countries implementing similar patient safety strategies.
    The Medical journal of Australia 06/2006; 184(10 Suppl):S65-8. · 2.85 Impact Factor

Full-text (2 Sources)

Available from
May 31, 2014